Celltrion Pharm Stock Profit Margin
| 068760 Stock | KRW 56,900 700.00 1.22% |
Celltrion Pharm fundamentals help investors to digest information that contributes to Celltrion Pharm's financial success or failures. It also enables traders to predict the movement of Celltrion Stock. The fundamental analysis module provides a way to measure Celltrion Pharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celltrion Pharm stock.
Celltrion |
Celltrion Pharm Company Profit Margin Analysis
Celltrion Pharm's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Celltrion Pharm Profit Margin | 0.09 % |
Most of Celltrion Pharm's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celltrion Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Celltrion Pharm has a Profit Margin of 0.0947%. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all Republic of Korea stocks is notably lower than that of the firm.
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Celltrion Fundamentals
| Return On Equity | 0.0891 | |||
| Return On Asset | 0.0341 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 5.87 T | |||
| Shares Outstanding | 34.05 M | |||
| Shares Owned By Insiders | 57.79 % | |||
| Shares Owned By Institutions | 6.75 % | |||
| Price To Earning | 62.82 X | |||
| Price To Sales | 8.22 X | |||
| Revenue | 398.74 B | |||
| Gross Profit | 72.93 B | |||
| EBITDA | 42.8 B | |||
| Net Income | 34.58 B | |||
| Cash And Equivalents | 80.19 B | |||
| Cash Per Share | 815.33 X | |||
| Total Debt | 39.4 B | |||
| Debt To Equity | 0.64 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 10,914 X | |||
| Cash Flow From Operations | 93.15 B | |||
| Target Price | 136000.0 | |||
| Number Of Employees | 29 | |||
| Beta | 0.23 | |||
| Market Capitalization | 2.1 T | |||
| Total Asset | 637.88 B | |||
| Retained Earnings | 30.6 B | |||
| Working Capital | 58.94 B | |||
| Current Asset | 144.21 B | |||
| Current Liabilities | 85.27 B | |||
| Z Score | 31.8 | |||
| Net Asset | 637.88 B |
About Celltrion Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celltrion Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celltrion Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celltrion Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Celltrion Stock
Celltrion Pharm financial ratios help investors to determine whether Celltrion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celltrion with respect to the benefits of owning Celltrion Pharm security.